Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Disha Malani

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|November 9, 2020
High-Content Imaging to Phenotype Human Primary and iPSC-Derived CellsLorenzo Veschini, Heba Sailem, Disha Malani, et al.
Scientific Reports|December 8, 2021
FLT3-ITD allelic ratio and HLF expression predict FLT3 inhibitor efficacy in adult AMLJarno Kivioja, Disha Malani, Ashwini Kumar, et al.
Bioinformatics (Oxford, England)|September 3, 2016
Drug response prediction by inferring pathway-response associations with kernelized Bayesian matrix factorizationMuhammad Ammad-Ud-Din, Suleiman A Khan, Disha Malani, et al.
Blood Advances|January 10, 2024
Monosomy 7/del(7q) cause sensitivity to inhibitors of nicotinamide phosphoribosyltransferase in acute myeloid leukemiaSamuli Eldfors, Joseph Saad, Nemo Ikonen, et al.
Cell Death & Disease|April 23, 2025
Mechanisms of chemotherapy failure in refractory/relapsed acute myeloid leukemia: the role of cytarabine resistance and mitochondrial metabolismSoo Yeon Chae, Se-Young Jang, Jinhui Kim, et al.
Scientific Reports|June 6, 2014
Quantitative scoring of differential drug sensitivity for individually optimized anticancer therapiesBhagwan Yadav, Tea Pemovska, Agnieszka Szwajda, et al.
Oncotarget|June 9, 2016
Intrinsic resistance to PIM kinase inhibition in AML through p38α-mediated feedback activation of mTOR signalingDiede Brunen, María José García-Barchino, Disha Malani, et al.
Cancer Research|April 4, 2019
Hemap: An Interactive Online Resource for Characterizing Molecular Phenotypes across Hematologic MalignanciesPetri Pölönen, Juha Mehtonen, Jake Lin, et al.
NPJ Precision Oncology|July 24, 2021
Bayesian multi-source regression and monocyte-associated gene expression predict BCL-2 inhibitor resistance in acute myeloid leukemiaBrian S White, Suleiman A Khan, Mike J Mason, et al.
Cancer Cell|July 11, 2020
Immunogenomic Landscape of Hematological MalignanciesOlli Dufva, Petri Pölönen, Oscar Brück, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Methods in Molecular Biology (Clifton, N.J.)|November 9, 2020
High-Content Imaging to Phenotype Human Primary and iPSC-Derived CellsLorenzo Veschini, Heba Sailem, Disha Malani, et al.
Scientific Reports|December 8, 2021
FLT3-ITD allelic ratio and HLF expression predict FLT3 inhibitor efficacy in adult AMLJarno Kivioja, Disha Malani, Ashwini Kumar, et al.
Bioinformatics (Oxford, England)|September 3, 2016
Drug response prediction by inferring pathway-response associations with kernelized Bayesian matrix factorizationMuhammad Ammad-Ud-Din, Suleiman A Khan, Disha Malani, et al.
Blood Advances|January 10, 2024
Monosomy 7/del(7q) cause sensitivity to inhibitors of nicotinamide phosphoribosyltransferase in acute myeloid leukemiaSamuli Eldfors, Joseph Saad, Nemo Ikonen, et al.
Cell Death & Disease|April 23, 2025
Mechanisms of chemotherapy failure in refractory/relapsed acute myeloid leukemia: the role of cytarabine resistance and mitochondrial metabolismSoo Yeon Chae, Se-Young Jang, Jinhui Kim, et al.
Scientific Reports|June 6, 2014
Quantitative scoring of differential drug sensitivity for individually optimized anticancer therapiesBhagwan Yadav, Tea Pemovska, Agnieszka Szwajda, et al.
Oncotarget|June 9, 2016
Intrinsic resistance to PIM kinase inhibition in AML through p38α-mediated feedback activation of mTOR signalingDiede Brunen, María José García-Barchino, Disha Malani, et al.
Cancer Research|April 4, 2019
Hemap: An Interactive Online Resource for Characterizing Molecular Phenotypes across Hematologic MalignanciesPetri Pölönen, Juha Mehtonen, Jake Lin, et al.
NPJ Precision Oncology|July 24, 2021
Bayesian multi-source regression and monocyte-associated gene expression predict BCL-2 inhibitor resistance in acute myeloid leukemiaBrian S White, Suleiman A Khan, Mike J Mason, et al.
Cancer Cell|July 11, 2020
Immunogenomic Landscape of Hematological MalignanciesOlli Dufva, Petri Pölönen, Oscar Brück, et al.
Pageof 2